US-FDA Filing

被引：0

|

作者：

Geetha, L. ^{[1
]}

Swarnakumari, P. ^{[1
]}

机构：

[1] MNR Coll Pharm, Sangareddy 502294, AP, India

来源：

INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2009年 / 71卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：191 / 191

页数：1

相关论文

共 50 条

[31] Votrient™ approved by the US FDA
O'Hare, Alice
FUTURE ONCOLOGY, 2012, 8 (06) : 648 - 648
[32] US awaits FDA appointment
Alicia Ault
Nature Medicine, 2001, 7 : 264 - 264
[33] Teriflunomide approved by the US FDA
O'Hare, Alice
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (06) : 615 - 615
[34] US FDA backs olestra
Ault, A
LANCET, 1998, 351 (9120): : 1942 - 1942
[35] FDA allows diclazuril in US
不详
EQUINE ATHLETE, 1998, 11 (02): : 9 - 9
[36] Information from US FDA
Journal of Chinese Pharmaceutical Sciences, 2018, (10) : 724 - 731
[37] US awaits FDA appointment
Ault, A
NATURE MEDICINE, 2001, 7 (03) : 264 - 264
[38] FDA proposes new systems and procedures for E-filing labeling and other data
Wechsler, J
BIOPHARM INTERNATIONAL, 2004, 17 (08) : 14 - +
[39] US FDA finalises US Celebrex label changes
Reactions Weekly, 2005, 1063 (1) : 2 - 2
[40] Abengoa bankruptcy filing affects projects in EU, US, Brazil
不详
SUGAR INDUSTRY-ZUCKERINDUSTRIE, 2016, 141 (01): : 22 - 22

← 1 2 3 4 5 →